bf/NASDAQ:SWTX_icon.jpeg

COM:SPRINGWORKSTX

SpringWorks Therapeutics

  • Stock

Last Close

37.44

21/11 21:00

Market Cap

2.93B

Beta: -

Volume Today

1.23M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-17.81M
-
-58.31M
227.32%
-45.57M
21.84%
-173.91M
281.60%
-277.42M
59.52%
-325.10M
17.19%
depreciation and amortization
17K
-
192K
1,029.41%
349K
81.77%
490K
40.40%
765K
56.12%
1.67M
117.91%
deferred income tax
605K
-
988K
63.31%
9.23M
-
stock based compensation
1.07M
-
3.11M
190.83%
10.03M
222.74%
38.44M
283.14%
72.97M
89.80%
94.53M
29.56%
change in working capital
2.02M
-
4.95M
144.78%
1.35M
72.79%
5.12M
280.24%
38.10M
644.49%
-583K
101.53%
accounts receivables
-5.93M
-
inventory
-3.10M
-
accounts payables
491K
-
1.88M
282.89%
-1.30M
169.36%
2.07M
259.05%
4.17M
100.96%
-196K
104.70%
other working capital
1.53M
-
3.07M
100.46%
2.65M
13.60%
3.04M
14.87%
33.94M
1,014.82%
9.23M
72.80%
other non cash items
2.61M
-
1.05M
59.87%
993K
5.34%
4.02M
304.93%
-2.54M
163.12%
net cash provided by operating activities
-14.71M
-
-47.44M
222.62%
-32.19M
32.15%
-127.88M
297.24%
-161.56M
26.34%
-222.79M
37.90%
investments in property plant and equipment
-293K
-
-670K
128.67%
-642K
4.18%
-2.02M
214.02%
-10.20M
405.75%
-7.38M
27.57%
acquisitions net
-3.59M
-
-3.50M
2.51%
2.02M
157.60%
-4.20M
308.33%
-2.80M
33.33%
purchases of investments
-3.59M
-
-442.69M
12,231.20%
-305.42M
31.01%
-481.05M
57.50%
-575.72M
19.68%
sales maturities of investments
3.59M
-
28M
679.17%
391.03M
1,296.54%
279.85M
28.43%
620.66M
121.78%
other investing activites
-3.59K
-
-2.02M
-
net cash used for investing activites
-293K
-
-4.26M
1,353.92%
-418.83M
9,731.74%
83.59M
119.96%
-215.60M
357.92%
34.75M
116.12%
debt repayment
common stock issued
169.73M
-
269.59M
58.84%
1.16M
99.57%
340.07M
29,292.05%
299.30M
11.99%
common stock repurchased
-1.34M
-
-2.80M
108.80%
dividends paid
other financing activites
50.38M
-
163.98M
225.51%
893K
99.46%
1.98M
-
139K
92.97%
net cash used provided by financing activities
50.38M
-
333.71M
562.43%
270.49M
18.95%
1.16M
99.57%
340.70M
29,347.02%
296.64M
12.93%
effect of forex changes on cash
net change in cash
35.38M
-
282.00M
697.14%
-180.54M
164.02%
-43.13M
76.11%
-36.46M
15.47%
108.60M
397.87%
cash at beginning of period
10.27M
-
46.19M
349.69%
328.19M
610.56%
147.65M
55.01%
104.53M
29.21%
68.07M
34.88%
cash at end of period
45.65M
-
328.19M
618.96%
147.65M
55.01%
104.53M
29.21%
68.07M
34.88%
176.67M
159.54%
operating cash flow
-14.71M
-
-47.44M
222.62%
-32.19M
32.15%
-127.88M
297.24%
-161.56M
26.34%
-222.79M
37.90%
capital expenditure
-293K
-
-670K
128.67%
-642K
4.18%
-2.02M
214.02%
-10.20M
405.75%
-7.38M
27.57%
free cash flow
-15.00M
-
-48.11M
220.78%
-32.83M
31.76%
-129.89M
295.62%
-171.76M
32.23%
-230.18M
34.01%

All numbers in (except ratios and percentages)